Literature DB >> 2727149

Creation of distal canine limb lymphedema.

H C Chen1, J J Pribaz, B M O'Brien, K R Knight, W A Morrison.   

Abstract

A canine model of distal limb lymphedema was established in order to study the treatment of this condition by lymph node transfer. This model was more difficult to establish than whole-limb lymphedema. Significant edema was achieved by a combination of preoperative irradiation and circumferential removal of skin from the irradiated areas followed by removal of the contents of the popliteal fossa. Despite these measures, it was not possible to produce lymphedema in every case, possibly because of the presence of lymphaticovenous shunts and panvascular compensation mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2727149     DOI: 10.1097/00006534-198906000-00016

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

1.  Transcapillary fluid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema.

Authors:  Tine V Karlsen; Marika J Karkkainen; Kari Alitalo; Helge Wiig
Journal:  J Physiol       Date:  2006-05-04       Impact factor: 5.182

2.  Validation of laser scanning confocal microscopy as a diagnostic method for lymphedema using a rat model.

Authors:  Song Jin; Changlian Zhang; YunJie Li; Sheng Li; Min Gao; Ting Wang; Lanbo Li; Guoren Yang; Yang Ou
Journal:  Lasers Med Sci       Date:  2020-08-06       Impact factor: 3.161

3.  Modification of a rodent hindlimb model of secondary lymphedema: surgical radicality versus radiotherapeutic ablation.

Authors:  Hyung Sub Park; In Mok Jung; Geum Hee Choi; Soli Hahn; Young Sun Yoo; Taeseung Lee
Journal:  Biomed Res Int       Date:  2013-11-14       Impact factor: 3.411

Review 4.  Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.

Authors:  Jerry F Hsu; Roy P Yu; Eloise W Stanton; Jin Wang; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.947

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.